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Abstract
Background: Thyroid gland lacks squamous epithelium (except in some rare situations like embroyonic remnants
or in inflammatory processes); for that reason the primary squamous cell carcinoma (SCC) of thyroid is extremely
rare entity, seen only in less than 1% of all thyroid malignancies and is considered almost fatal. So, far, only few
case reports have been published in literature.
Case presentation: Herein we present a 54 years old Saudi female with 3 months history of progressive neck
swelling and hoarse voice, who was referred to us by her primary care physician as suspected case of anaplastic
carcinoma of thyroid for radical external beam radiation therapy (EBRT). Fine Needle aspiration cytology (FNAC)
revealed squamous cell carcinoma. Computed tomography (CT) neck showed 10 × 10 cm mass in left lobe of
thyroid invading trachea and skin. Extensive staging work up ruled out the possibility of any primary site of SCC
other than thyroid gland. Tumor was found unresectable and was referred to radiation oncology. She received
palliative EBRT 30 Gy in 10 fractions. After completion of EBRT, there was progression of disease and patient died 3
months after completion of EBRT by airway compromise.
Conclusion: Primary SCC of thyroid is rare and aggressive entity. FNAC is reliable and effective tool for immediate
diagnosis. Surgery is a curative option, but it is not always possible as most of cases present as locally advanced
with adjacent organs involvement. EBRT alone was found ineffective. Aggressive combined modality (debulking
surgery, radiation and chemotherapy) shall be considered for such cases.
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Background
Primary squamous cell carcinoma (SCC) of thyroid is an
uncommon malignancy and has poor prognosis [1].
SCC of thyroid constitutes less than 1% of thyroid
malignancies and has been found fatal within one year
of initial diagnosis [2]. The median age is fifth and sixth
decade, but can be seen at any age. Main cause of death
in these patients is secondary to respiratory interference
by direct invasion or compression of the trachea [3].
When SCC of thyroid is diagnosed, the possibility of the
tumor arising from adjacent organs (esophagus, larynx)
or representing metastatic disease from primary growth
somewhere else (lungs) must be considered before con-
cluding the malignancy as SCC of thyroid.
The etiology of SCC thyroid is uncertain as thyroid
gland lacks the squamous epithelium. However three the-
ories have been postulated; first the embryonic nest theory
suggests that squamous cells are derived from the embryo-
nic remnants such thyroglossal duct, thymic epithelium
and ultimobronchial body [4]. Second the metaplasia the-
ory suggests that the environmental stimuli (inflammation
and Hashimoto’s thyroiditis) result in squamous metapla-
sia [5]. Third the de-differentiation theory suggests that
existing papillary, follicular, medullary and anaplastic thyr-
oid carcinoma de-differentiate into SCC [6,7].
Herein we present a case of 54 years old Saudi lady
with locally advanced primary squamous cell carcinoma
of thyroid, diagnosed by fine needle aspiration cytology
(FNAC) was treated with radiation therapy.
Case presentation
A 54 year old Saudi female presented in our clinic with
neck swelling and hoarse voice. She had noticed this
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any medium, provided the original work is properly cited.swelling for 3 months and it had been rapidly increasing
in size over a week causing dyspnoea and dysphagia to
solids. Her previous medical history revealed type II dia-
betes mellitus since last 10 years and hypothyroidism
since last 3 years, for that she was taking thyroxin 50
micrograms daily and metformin. She had no history of
smoking and her weight was stable.
On physical examination, her vitals were stable. A
fixed hard neck mass of size 8 × 8 cm was palpable in
the left thyroid lobe with inflammatory surface Figure 1.
There was no palpable cervical lymphadenopathy and
examination of chest, heart, nervous system and abdo-
men was normal. Clinical differential diagnosis was ana-
plastic carcinoma of thyroid.
Ultrasonography showed huge left thyroid lobe par-
tially cystic and solid mass of size 8.5 × 9 cm. Com-
puted tomography (CT) neck showed 10 × 10 cm mass
in left lobe of thyroid, partially necrotic invading to
adjacent skin and trachea and no lymphadenopathy was
found Figure 2. Serum T4, thyroid stimulating hormone
(TSH), thyroglobulin and serum calcium were within
normal limits. Fine needle aspiration cytology (FNAC)
of mass was performed, which revealed squamous cell
carcinoma Figure 3. Differential diagnosis was metastatic
Figure 1 A fixed hard neck mass of size 8 × 8 cm was palpable
in the left thyroid lobe with inflammatory surface.
Figure 2 Computed tomography (CT) neck showing 10 × 10
cm mass in left lobe of thyroid, partially necrotic invading to
adjacent skin and trachea and no cervical lymphadenopathy.
Figure 3 Fine needle aspiration cytology (FNAC) showing nests
of pleomorphic cells with abundant eosinophilic cytoplasm
and keratin formation along with intercellular bridging.
Figure 4 Bone scintigraphy showing no evidence of distant
bone metastasis.
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Author [Ref] Gender/Age Presentation Stage Associated
Problem
Treatment given Survival Comments
Zimmer PW
[1]
Female/64
years
Asymptomatic neck
mass
T2N0M0 - Total thyroidectomy 7
months
-
Kebapci N [7] Female/25
years
Right neck mass T4N1M0 Hashimotos’
thyroiditis
Papillary
carcinoma
Total
thyroidectomy
and RAI
therapy
44 months -
Ko YS [8] Male/87 years Asymptomatic neck
mass
T4N0M0 - Right lobectomy NA CK5/6 +
CK19 +
EMA,p53 focal +
BRAF mutation +
Mercante G
[9]
Male/67 years - T2N0M0 Follicular
carcinoma
Lobe-isthmusectomy +
Adjuvant chemoradiation
2 years -
De Vos FY
[10]
- Neck mass T4N0M0 - Induction chemotherapy
(Cisplatin + paclitaxel)
Total
thyroidectomy
20 months Induction
chemotherapy
resulted in R0
resection
Yucel H [11] Male/88 years Neck mass T4N0M0 Hyperthyroidism Total thyroidectomy
Adjuvant radiation therapy
6
months
Patient RAI therapy 20
years back
Eorn TI [12] Female/43
years
Neck mass T3N0M0 Papillary
carcinoma
Total thyroidectomy
Adjuvant radiation therapy
59.4 Gy
And RAI
8
months
CK7 +
p6 3+
Makay O [13] Male/53 years
Male/71 years
Neck mass, hoarse
voice and weight
loss
T3N0M0 - Near total thyroidectomy
Chemoradiation 50 Gy +
Doxorubicin and
cyclophosphamide
2
months
4
months
5
months
-
Fassan M [17] Female/64
years
Neck mass T3N0M0 Goiter Total thyroidectomy NA CK 5/6 +
CK 7 +
CK 19 +
Maamouri F
[18]
Female/87
years
Right neck mass T3N0M0 Papillary
carcinoma
Total thyroidectomy
And RAI therapy
6
months
-
Chintamani
[14]
Female/50
years
Male/60 years
Male/58 years
Dysphagia, hoarse
voice and stridor
T4N0M0 Hyperthyroidism Total thyroidectomy
Adjuvant radiotherapy 50
Gy
12
months
-
Jung TS [15] Male/56 years Neck mass, hoarse
voice
T3N0M0 Follicular
carcinoma
Total thyroidectomy
Adjuvant radiotherapy 50
Gy
8 years -
Sutak J [19] Female/80
years
Asymptomatic neck
mass
T4N1M0 Tall cell variant
papillary
carcinoma
Total thyroidectomy - CK 7 +
CK 19 +
CK AE1/3 +
P53 focal +
Zhou XH [16] 4 patients NA T4N0M0 - Total thyroidectomy
Adjuvant radiotherapy 50
Gy + chemotherapy
4
months
6
months
13
months
26
months
Longer survival was
seen in combined
trimodality treatment
Lam KY [20] 4 females/71
years
Neck mass,
stridor
T4N0M0 - Total thyroidectomy 4
months
CK 7 +
CK 19 +
CK AE1/3 +
P53 focal +
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CT chest, abdomen, pelvis, magnetic resonance imaging
(MRI) of head and neck region, pan-endoscopy, laryngo-
scopy, esophagoscopy and bone scintigraphy did not
reveal any primary lesion or other metastatic disease
Figure 4. Radiological stage was made as T4N0M0.
In a multidisciplinary tumor (MDT) meeting it was
labeled unresectable and patient was referred for exter-
nal beam radiation therapy (EBRT) after prophylactic
percutaneous endoscopic gastrostomy (PEG) insertion.
Due to retrosternal extention of disease, tracheostomy
was deferred. Patient received 30 Grays (Gy) in 10 frac-
tions to thyroid. Post radiation therapy, there was pro-
gression size of neck mass with progressive dyspnoea.
Patient died of airway compromise 3 months of pallia-
tive EBRT.
Discussion
Primary SCC of the thyroid gland is an extremely rare
and aggressive entity usually presents with classic triad
features; (I) rapidly enlarging mass in the older patients
behaving like anaplastic carcinoma, (II) it may be asso-
ciated with other thyroid malignancies and (III) histolo-
gical features of intercellular bridges and keratin [8-10].
FNAC is reliable and confirmatory tool, but it is manda-
tory to exclude the metastatic SCC [11].
Treatment with surgery, radiation therapy and che-
motherapy alone has been found ineffective in pre-
viously published similar case reports, as majority of
these patients present as locally advanced cases not
amenable for curative resection Table 1. The better sur-
vival rates have been achieved with aggressive combina-
tion therapy (surgery followed by adjuvant radiation
therapy (50-60 Gy) with or without chemotherapy or
induction chemotherapy followed by surgery) [11-16].
Conclusion
Primary squamous cell carcinoma of thyroid is a rare
and aggressive entity with poor prognosis. FNAC is
effective confirmatory tool, but efforts shall be made to
rule out metastatic SCC originating from other sites.
Surgery, radiotherapy and chemotherapy alone are inef-
fective. Aggressive treatment with surgery followed by
adjuvant radiotherapy with or without chemotherapy is
recommended to achieve better outcome.
Consent
Written permission was taken from the patient for pub-
lication of the case report.
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